2025 Hormone-Dependent Cancers Gordon Research Conference (August 10 - 15, 2025)

The Hormone-Dependent Cancers GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

The 2025 Gordon Research Conference on Hormone-Dependent Cancers: A Place in Time - The Global and Cellular Significance of Environment and Tumour Dynamics on Disease Progression will provide an open and engaging forum on how we can employ the latest innovations to better understand the impact of the environment, the microenvironment and therapeutic pressure on steroid driven tumour progression.

Presentations

Doctors Fang Xie, Larysa Poluben, Betul Ersoy, and Mannan Nouri accompanied Dr. Balk to this conference held in Newry, Maine at the Sunday River resort between August 10 - 15, 2025.

Lightning Talk, Mannan Nouri

Dr. Nouri conducted a lightning talk describing his work in the Balk on post-translational modifications of the pioneer transcription factor, FOXA1.

All attendees from the Balk lab presented posters at the conference, and Dr. Nouri was invited to give a lightning talk on his project.

'Keynote Session: Understanding Tumor Evolution as the Key to Precision Oncology'

On the final evening of the conference, Dr. Balk gave the keynote alongside Dr. Mark Rubin (University of Bern, Switzerland).  Dr. Balk's seminar was entitled "Prostate Cancer Evolution in Response to AR Pathway Inhibition and Taxane Therapies", and featured selected data from recent work within his research program.

Balk Lab- at the GRC 2025